Company Filing History:
Years Active: 2005
Title: Eberhard Schneider: Innovator in Nucleic Acid Conjugates
Introduction
Eberhard Schneider is a notable inventor based in Kelkheim, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid conjugates. His innovative work has led to advancements in methods for sorting and immobilizing nucleic acids, which are crucial for various applications in molecular biology.
Latest Patents
Eberhard Schneider holds a patent for the "Enzymatic modification of a nucleic acid-synthetic binding unit conjugate." This invention relates to conjugates of synthetic binding units and nucleic acids. The patent outlines methods for sorting and immobilizing nucleic acids on support materials using these conjugates. It emphasizes specific molecular addressing of nucleic acids mediated by synthetic binding systems. Furthermore, the invention introduces novel methods for utilizing these conjugates in active electronic array systems, producing innovative array constructs for various nucleic acid assay formats. The patent also discusses improved methods for making solid-phase synthesized conjugates and the use of these conjugates as substrates for enzymatic reactions, including nucleic acid amplification reactions. Eberhard Schneider's work in this area has the potential to enhance the efficiency and effectiveness of nucleic acid assays.
Career Highlights
Eberhard Schneider is associated with Nanogen Recognomics GmbH, where he continues to develop and refine his innovative ideas. His work has positioned him as a key figure in the biotechnology sector, particularly in the development of synthetic binding units and their applications in nucleic acid research.
Collaborations
Eberhard Schneider has collaborated with notable colleagues, including Markus Schweitzer and Richard R. Anderson. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Eberhard Schneider's contributions to the field of biotechnology, particularly through his patent on nucleic acid-synthetic binding unit conjugates, highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to influence the development of new methodologies in molecular biology.